Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-27

Clinical Trial Update: Remote Observed Dosing of Suboxone to Improve Clinical Practice [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating remote observed dosing of Suboxone (buprenorphine/naloxone) to inform clinical practice for opioid-use disorder; the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)

Snippet

Sponsor: University of Pennsylvania | Conditions: Opioid-use Disorder, Opioid Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-27